Miral, Fhebie Glein H.

HRN: 04-39-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2026
CEFUROXIME 500MG (TAB)
06/11/2026
06/17/2026
PO
500
BID
7 Days
Remove - Pending Acceptance
06/11/2026
METRONIDAZOLE 500MG (TAB)
06/11/2026
06/17/2026
PO
500
TID
THICKLY MSAF
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: